110 related articles for article (PubMed ID: 1598660)
1. Long-term follow-up of 92 patients with locally advanced follicular or papillary thyroid cancer after combined treatment.
Glanzmann C; Lütolf UM
Strahlenther Onkol; 1992 May; 168(5):260-9. PubMed ID: 1598660
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
[TBL] [Abstract][Full Text] [Related]
3. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition.
Chow SM; Yau S; Kwan CK; Poon PC; Law SC
Endocr Relat Cancer; 2006 Dec; 13(4):1159-72. PubMed ID: 17158761
[TBL] [Abstract][Full Text] [Related]
4. [Papillary and follicular thyroid carcinoma: long-term course in 339 patients of the Zurich University Hospital 1960 to 1988 and review].
Glanzmann C; Lütolf UM
Schweiz Rundsch Med Prax; 1992 Apr; 81(15):457-67. PubMed ID: 1565936
[TBL] [Abstract][Full Text] [Related]
5. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
McHenry C; Jarosz H; Lawrence AM; Paloyan E
Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754
[TBL] [Abstract][Full Text] [Related]
6. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
7. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
8. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
9. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
[TBL] [Abstract][Full Text] [Related]
10. Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience.
Terezakis SA; Lee KS; Ghossein RA; Rivera M; Tuttle RM; Wolden SL; Zelefsky MJ; Wong RJ; Patel SG; Pfister DG; Shaha AR; Lee NY
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):795-801. PubMed ID: 18676097
[TBL] [Abstract][Full Text] [Related]
11. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
[TBL] [Abstract][Full Text] [Related]
13. Thyroid cancer: a multivariate analysis on influence of treatment on long-term survival.
Staunton MD
Eur J Surg Oncol; 1994 Dec; 20(6):613-21. PubMed ID: 7995409
[TBL] [Abstract][Full Text] [Related]
14. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
Menzel C; Grünwald F; Schomburg A; Palmedo H; Bender H; Späth G; Biersack HJ
J Nucl Med; 1996 Sep; 37(9):1496-503. PubMed ID: 8790201
[TBL] [Abstract][Full Text] [Related]
15. Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer.
Seaberg RM; Eski S; Freeman JL
Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):355-9. PubMed ID: 19380356
[TBL] [Abstract][Full Text] [Related]
16. Treatment of locally aggressive well-differentiated thyroid cancer.
Martins AS; Melo GM; Valério JB; Langner E; Lage HT; Tincani AJ
Int Surg; 2001; 86(4):213-9. PubMed ID: 12056464
[TBL] [Abstract][Full Text] [Related]
17. Papillary and follicular thyroid cancer: impact of treatment in 1578 patients.
Simpson WJ; Panzarella T; Carruthers JS; Gospodarowicz MK; Sutcliffe SB
Int J Radiat Oncol Biol Phys; 1988 Jun; 14(6):1063-75. PubMed ID: 2454902
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years.
Brierley J; Tsang R; Panzarella T; Bana N
Clin Endocrinol (Oxf); 2005 Oct; 63(4):418-27. PubMed ID: 16181234
[TBL] [Abstract][Full Text] [Related]
19. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.
Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK
Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.
Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM
Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
